8-K ·Filed Apr 20, 2026
ON

ONMDW

OneMedNet Corp
BEARISH
Impact 8/10
Horizonweeks Processed5mo ago SEC0001493152-26-018129
8-K context-dependent: Items 3.01
Actionable Insight ▼ Bearish

Monitor bid price daily for signs of recovery above $1.00 for 10 consecutive days; watch for announcements regarding a reverse stock split or other compliance measures. Delisting would severely limit institutional ownership and trading liquidity.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
ONMDW ▼ -53.92% at T+60d
SHORT call ✓ call won +53.92% · α vs SPY +60.82% · entry $0.0740 → $0.0341
Entry anchored
Apr 20, 2026
via day open
T+1d
0.00%
call 0.00% · α +1.02%
$0.0740
settled 5mo ago
T+5d
0.00%
call 0.00% · α +1.08%
$0.0740
settled 5mo ago
T+20d
0.00%
call 0.00% · α +4.92%
$0.0740
settled 5mo ago
T+60d
-53.92%
call +53.92% · α +60.82%
$0.0341
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

OneMedNet Corp (ONMDW) received a delisting notice from Nasdaq due to non-compliance with the $1.00 minimum bid price requirement for 30 consecutive business days. The company has until October 12, 2026, to regain compliance, potentially through a reverse stock split. Failure to comply could result in delisting, severely impacting liquidity and investor access.

Key Facts

  • Received Nasdaq delisting notice on April 14, 2026, for failing to maintain a $1.00 minimum bid price for 30 consecutive days
  • Has 180-day compliance period ending October 12, 2026, to regain compliance by maintaining a $1.00+ bid price for 10 consecutive business days
  • May qualify for an additional 180-day grace period if it meets other listing standards and files intent to cure, potentially via reverse stock split
  • Company has market cap of $2M and is at risk of delisting if no corrective action is taken

Financial Impact

High risk of delisting if bid price does not recover; potential reverse stock split could materially dilute shareholders or signal distress

liquidityshare priceinvestor basemarket perception

Risk Factors

  • Actual delisting from Nasdaq, leading to reduced liquidity and investor access
  • Reverse stock split could dilute shareholders and be perceived as a distress signal
  • Further decline in share price and market confidence if compliance is not achieved

Market Snapshot

Exchange
Nasdaq
Sector
Services-Commercial Physical & Biological Research

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-018129
Document: 0001493152-26-018129-index-headers.html0001493152-26-018129
Document: 0001493152-26-018129-index.html0001493152-26-018129
Document: 0001493152-26-018129.txt0001493152-26-018129

US Market Status

Market Closed — Opens Mon (37h 40m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access